Notice Pursuant to the National Cooperative Research and Production Act of 1993-Customer Experience Hub, 52093-52094 [2024-13623]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Applied Engineering
Management Corp., Herndon, VA; Fors
Marsh Group, Arlington, VA; Parallax
Advanced Research Corp., Beavercreek,
OH; and Revelio Labs, Inc., New York,
NY, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ADC intends
to file additional written notifications
disclosing all changes in membership.
On November 11, 2021, ADC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on December 22, 2021 (86 FR
72628).
The last notification was filed with
the Department on January 11, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on February 6, 2024 (89 FR 8245).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13613 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
ddrumheller on DSK120RN23PROD with NOTICES1
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Customer Experience
Hub
Notice is hereby given that, on April
17, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Customer
Experience Hub (‘‘CX Hub’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Specifically, 3 Aware LLC,
Indianapolis, IN; Adeco LLC, Houston,
TX; AGAPE Strategic Solutions of
Maryland LLC, Hyattsville, MD;
Alliance NCTN Foundation, Chicago, IL;
Allvivo Vascular, Inc., Lake Forest, CA;
American Cancer Society Cancer Action
Network, Washington, DC; American
Cancer Society, Inc., Atlanta, GA;
VerDate Sep<11>2014
17:46 Jun 20, 2024
Jkt 262001
American College of Radiology, Reston,
VA; American Military Families Action
Network, Tacoma, WA; Apricity Health,
Inc., Houston, TX; Artyc PBC, Fremont,
CA; Asante Bio, Tampa, FL; Austin
Healthcare Council, Austin, TX; Baylor
Research Institute dba Baylor Scott &
White Research Institute, Dallas, TX;
Beth Israel Lahey Health, Cambridge,
MA; Betty’s Health Company LLC dba
Betty’s Co., San Antonio, TX;
BioInnovation Labs dba BioLabs,
Cambridge, MA; BioNorthTexas
Foundation, Irving, TX; Boston
University, Boston, MA; Breathe
Chicago Center at University of Illinois
Chicago, Chicago, IL; Capital Factory
Properties LLC, Austin, TX; Care Access
Research LLC, Boston, MA; Carson
Leslie Foundation, Dallas, TX;
CentanniPark LLC, Somerville, MA;
Central Indiana Corporate Partnership,
Indianapolis, IN; CFD Research Corp.,
Huntsville, AL; Charles River Analytics,
Inc., Cambridge, MA; Chicago ARC,
Glenview, IL; Children’s Cancer
Therapy Development Institute,
Hillsboro, OR; Clarivate Analytics (US)
LLC, Ann Arbor, MI; Clinical Research
Philadelphia LLC, Philadelphia, PA;
Clinical Trials Transformation Initiative,
Durham, NC; CliniOps, Inc., Fremont,
CA; Cogitativo, Inc., Berkeley, CA;
Critical Path Institute, Tucson, AZ;
Cromtec Cyber Solutions, Inc., Houston,
TX; Cx Precision Medicine, Fort Worth,
TX; Dallas-Fort Worth Hospital Council,
Irving, TX; Datavant, Inc., Phoenix, AZ;
Decentralized Trials & Research
Alliance (DTRA), San Diego, CA; DHR
Health Institute for Research &
Development, Edinburg, TX; Digital
Medicine Society, Inc., Boston, MA;
Driscoll Children’s Hospital, Corpus
Christi, TX; Duke University, Durham,
NC; Endpoint Health, Palo Alto, CA;
Environmental Information Systems
Corp., Las Vegas, NV; Every Cure,
Philadelphia, PA; Evidation Health, San
Mateo, CA; Exo Imagining, Inc., Santa
Clara, CA; Florida Institute of
Technology, Inc., Melbourne, FL;
Freyya, Inc., San Antonio, TX; Genetic
Alliance, Inc., Damascus, MD; Global
Coalition for Adaptive Research, Inc.,
Larkspur, CA; Guava Health, Inc., Santa
Barbara, CA; Gulf South Clinical Trials
Network, New Orleans, LA; Halo Health
Systems, Plano, TX; Hamilton Health
Box, Inc., Houston, TX; Harvard T.H.
Chan School of Public Health, Boston,
MA; Health Level Seven International,
Inc., Ann Arbor, MI; Health Tech
Austin, Austin, TX; Health Wildcatters,
Dallas, TX; Healthcare Innovators
Professional Society, Houston, TX; Hero
Medical Technologies, Inc., Ponte Vedra
Beach, FL; Hope Biosciences LLC, Sugar
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
52093
Land, TX; Huck Medical Technologies,
Inc., Jacksonville, FL; Indiana
University, Bloomington, IN; Insilicom
LLC, Tallahassee, FL; Institute for
Systems Biology, Seattle, WA; Iowa
State University of Science and
Technology, Ames, IA; IQVIA
Government Solutions, Inc., Falls
Church, VA; iTrials, Ashburn, VA;
JAKTOOL LLC, Cranbury, NJ;
LaunchBio, Inc., San Diego, CA; Levels
Health, Austin, TX; Lone Star Stroke
Research Consortium, San Antonio, TX;
Mary Crowley Cancer Research, Dallas,
TX; Massachusetts Health & Hospital
Association, Burlington, MA; MATRIX
AI Consortium, San Antonio, TX; Mayo
Clinic, Rochester, MN; Meadows Mental
Health Policy Institute, Dallas, TX;
Mercury Data Science, Inc. dba
OmniScience, Houston, TX; Milken
Institute, Washington, DC; Modern
Trials, Inc., Haddon Township, NJ;
Momentum Design Lab LLC, San Mateo,
CA; MPR Associates, Inc., Alexandria,
VA; Music Beats Cancer, Washington,
DC; MyEyes LLC, Heber, UT; NanOlogy
LLC, Fort Worth, TX; Neelyx Labs, Inc.,
Wood Dale, IL; Panthera BioSolutions,
Fort Worth, TX; Persown, Inc.,
Jacksonville, FL; Phage Refinery LLC,
San Antonio, TX; Polaris Alpha
Advanced Systems, Inc.,
Fredericksburg, VA; Precise
Populations, Austin, TX; Providence
Health & Services, Renton, VA; Quality
by Randomization Ltd. dba Protas,
Salford, UNITED KINGDOM; Quantum
Leap Healthcare Collaborative, San
Francisco, CA; Quidel Corp. dba
QuidelOrtho, San Diego, CA;
Radiological Society of North America,
Inc., Oak Brook, IL; Retina Foundation,
Dallas, TX; Rhode Island Health Center
Association, Providence, RI; Rock
Health Foundation, San Francisco, CA;
Ruth Health, Bronx, NY; Safe Health
Systems, Inc., Scottsdale, AZ; San Diego
State University Foundation, San Diego,
CA; Segal Design Institute at
Northwestern University, Evanston, IL;
Seven Bridges Genomics, Inc., Boston,
MA; SiteBridge Research, Inc., Chapel
Hill, NC; Southern Research Institute,
Birmingham, AL; Spark Biomedical,
Inc., Dallas, TX; SRI International,
Menlo Park, CA; St. Mary’s University
of San Antonio, Texas, San Antonio,
TX; SygnaMap, Inc., San Antonio, TX;
Systems & Technology Research LLC,
Woburn, MA; Texas A&M University
System Health Science Center, Bryan,
TX; The Children’s Hospital of
Philadelphia, Philadelphia, PA; The
Medical College of Wisconsin, Inc.,
Milwaukee, WI; The Medical University
of South Carolina, Charleston, SC; The
Methodist Hospital Research Institute,
E:\FR\FM\21JNN1.SGM
21JNN1
52094
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
Houston, TX; The Regents of the
University of California, San Francisco,
San Francisco, CA; The University of
Kansas Medical Center Research
Institute, Inc., Kansas City, KS; The
University of Texas at Arlington,
Arlington, TX; The University of Texas
Health Science Center at San Antonio,
San Antonio, TX; Tonix
Pharmaceuticals, Chatham, NJ;
TQIntelligence, Inc., Tucker, GA;
Tremedics Medical Devices LLC, Fort
Worth, TX; Trustees of the University of
Pennsylvania dba Clinical Practices of
the University of Pennsylvania,
Philadelphia, PA; UC Berkeley Haas
Institute for Business Innovation,
Berkeley, CA; UCSF: Eureka Research
Platform, San Francisco, CA; University
of Alabama at Birmingham,
Birmingham, AL; University of Chicago,
Chicago, IL; University of Colorado
Anschutz Medical Campus, Aurora, CO;
University of Iowa, Iowa City, IA;
University of Massachusetts Medical
School, Worcester, MA; University of
the Virgin Islands, St. Thomas, VI;
University of Utah, Salt Lake City, UT;
Vanderbilt University Medical Center,
Nashville, TN; Women’s Health Access
Matters, Greenwich, CT; Yunu, Inc.,
Cary, NC; and ZS Associates, Inc.,
Evanston, IL, have been added as parties
to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and the CX Hub
intends to file additional written
notifications disclosing all changes in
membership.
On January 11, 2024, the CX Hub filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on April 16, 2024 (89 FR
26929).
[FR Doc. 2024–13623 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
ddrumheller on DSK120RN23PROD with NOTICES1
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Senior Healthcare
Innovation Consortium
Notice is hereby given that, on April
4, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
17:46 Jun 20, 2024
Jkt 262001
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13614 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—DVD Copy Control
Association
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
VerDate Sep<11>2014
et seq. (‘‘the Act’’), Senior Healthcare
Innovation Consortium (SHIC) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Specifically, Access Sensor
Technologies LLC, Fort Collins, CO;
Clarivate Analytics (US) LLC, Ann
Arbor, MI; EchoCare, Ness Ziona,
ISRAEL; GaitBetter, Rockville, MD; and
North Dakota State University, Fargo,
ND, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and SHIC intends
to file additional written notifications
disclosing all changes in membership.
On November 02, 2022, SHIC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on November 23, 2022 (87 FR
71677).
The last notification was filed with
the Department on January 9, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on February 6, 2024 (89 FR 8245).
Notice is hereby given that, on April
24, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), the DVD Copy
Control Association (‘‘DVD CCA’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Specifically, Nuvoton Technology
Corporation, Kyoto, JAPAN, has been
added as a party to this venture.
Also, Fuji Film Media Crest Co., Ltd.,
Tokyo, JAPAN, has withdrawn as a
party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and DVD CCA
intends to file additional written
notifications disclosing all changes in
membership.
On April 11, 2001, DVD CCA filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on August 3, 2001 (66 FR 40727).
The last notification was filed with
the Department on December 20, 2023.
A notice was published in the Federal
Register pursuant to section 6(b) of the
Act on February 6, 2024 (89 FR 8244).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13628 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc.
Notice is hereby given that, on May 6,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), UHD Alliance, Inc.
(‘‘UHD Alliance’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, XGIMI Technology Co.,
Ltd., Chengdu, PEOPLE’S REPUBLIC OF
CHINA, has been added as a party to
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
section 6(a) of the Act. The Department
E:\FR\FM\21JNN1.SGM
21JNN1
]]>Agencies
[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52093-52094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13623]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Customer Experience Hub
Notice is hereby given that, on April 17, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub (``CX
Hub'') has filed written notifications simultaneously with the Attorney
General and the Federal Trade Commission disclosing changes in its
membership. The notifications were filed for the purpose of extending
the Act's provisions limiting the recovery of antitrust plaintiffs to
actual damages under specified circumstances.
Specifically, 3 Aware LLC, Indianapolis, IN; Adeco LLC, Houston,
TX; AGAPE Strategic Solutions of Maryland LLC, Hyattsville, MD;
Alliance NCTN Foundation, Chicago, IL; Allvivo Vascular, Inc., Lake
Forest, CA; American Cancer Society Cancer Action Network, Washington,
DC; American Cancer Society, Inc., Atlanta, GA; American College of
Radiology, Reston, VA; American Military Families Action Network,
Tacoma, WA; Apricity Health, Inc., Houston, TX; Artyc PBC, Fremont, CA;
Asante Bio, Tampa, FL; Austin Healthcare Council, Austin, TX; Baylor
Research Institute dba Baylor Scott & White Research Institute, Dallas,
TX; Beth Israel Lahey Health, Cambridge, MA; Betty's Health Company LLC
dba Betty's Co., San Antonio, TX; BioInnovation Labs dba BioLabs,
Cambridge, MA; BioNorthTexas Foundation, Irving, TX; Boston University,
Boston, MA; Breathe Chicago Center at University of Illinois Chicago,
Chicago, IL; Capital Factory Properties LLC, Austin, TX; Care Access
Research LLC, Boston, MA; Carson Leslie Foundation, Dallas, TX;
CentanniPark LLC, Somerville, MA; Central Indiana Corporate
Partnership, Indianapolis, IN; CFD Research Corp., Huntsville, AL;
Charles River Analytics, Inc., Cambridge, MA; Chicago ARC, Glenview,
IL; Children's Cancer Therapy Development Institute, Hillsboro, OR;
Clarivate Analytics (US) LLC, Ann Arbor, MI; Clinical Research
Philadelphia LLC, Philadelphia, PA; Clinical Trials Transformation
Initiative, Durham, NC; CliniOps, Inc., Fremont, CA; Cogitativo, Inc.,
Berkeley, CA; Critical Path Institute, Tucson, AZ; Cromtec Cyber
Solutions, Inc., Houston, TX; Cx Precision Medicine, Fort Worth, TX;
Dallas-Fort Worth Hospital Council, Irving, TX; Datavant, Inc.,
Phoenix, AZ; Decentralized Trials & Research Alliance (DTRA), San
Diego, CA; DHR Health Institute for Research & Development, Edinburg,
TX; Digital Medicine Society, Inc., Boston, MA; Driscoll Children's
Hospital, Corpus Christi, TX; Duke University, Durham, NC; Endpoint
Health, Palo Alto, CA; Environmental Information Systems Corp., Las
Vegas, NV; Every Cure, Philadelphia, PA; Evidation Health, San Mateo,
CA; Exo Imagining, Inc., Santa Clara, CA; Florida Institute of
Technology, Inc., Melbourne, FL; Freyya, Inc., San Antonio, TX; Genetic
Alliance, Inc., Damascus, MD; Global Coalition for Adaptive Research,
Inc., Larkspur, CA; Guava Health, Inc., Santa Barbara, CA; Gulf South
Clinical Trials Network, New Orleans, LA; Halo Health Systems, Plano,
TX; Hamilton Health Box, Inc., Houston, TX; Harvard T.H. Chan School of
Public Health, Boston, MA; Health Level Seven International, Inc., Ann
Arbor, MI; Health Tech Austin, Austin, TX; Health Wildcatters, Dallas,
TX; Healthcare Innovators Professional Society, Houston, TX; Hero
Medical Technologies, Inc., Ponte Vedra Beach, FL; Hope Biosciences
LLC, Sugar Land, TX; Huck Medical Technologies, Inc., Jacksonville, FL;
Indiana University, Bloomington, IN; Insilicom LLC, Tallahassee, FL;
Institute for Systems Biology, Seattle, WA; Iowa State University of
Science and Technology, Ames, IA; IQVIA Government Solutions, Inc.,
Falls Church, VA; iTrials, Ashburn, VA; JAKTOOL LLC, Cranbury, NJ;
LaunchBio, Inc., San Diego, CA; Levels Health, Austin, TX; Lone Star
Stroke Research Consortium, San Antonio, TX; Mary Crowley Cancer
Research, Dallas, TX; Massachusetts Health & Hospital Association,
Burlington, MA; MATRIX AI Consortium, San Antonio, TX; Mayo Clinic,
Rochester, MN; Meadows Mental Health Policy Institute, Dallas, TX;
Mercury Data Science, Inc. dba OmniScience, Houston, TX; Milken
Institute, Washington, DC; Modern Trials, Inc., Haddon Township, NJ;
Momentum Design Lab LLC, San Mateo, CA; MPR Associates, Inc.,
Alexandria, VA; Music Beats Cancer, Washington, DC; MyEyes LLC, Heber,
UT; NanOlogy LLC, Fort Worth, TX; Neelyx Labs, Inc., Wood Dale, IL;
Panthera BioSolutions, Fort Worth, TX; Persown, Inc., Jacksonville, FL;
Phage Refinery LLC, San Antonio, TX; Polaris Alpha Advanced Systems,
Inc., Fredericksburg, VA; Precise Populations, Austin, TX; Providence
Health & Services, Renton, VA; Quality by Randomization Ltd. dba
Protas, Salford, UNITED KINGDOM; Quantum Leap Healthcare Collaborative,
San Francisco, CA; Quidel Corp. dba QuidelOrtho, San Diego, CA;
Radiological Society of North America, Inc., Oak Brook, IL; Retina
Foundation, Dallas, TX; Rhode Island Health Center Association,
Providence, RI; Rock Health Foundation, San Francisco, CA; Ruth Health,
Bronx, NY; Safe Health Systems, Inc., Scottsdale, AZ; San Diego State
University Foundation, San Diego, CA; Segal Design Institute at
Northwestern University, Evanston, IL; Seven Bridges Genomics, Inc.,
Boston, MA; SiteBridge Research, Inc., Chapel Hill, NC; Southern
Research Institute, Birmingham, AL; Spark Biomedical, Inc., Dallas, TX;
SRI International, Menlo Park, CA; St. Mary's University of San
Antonio, Texas, San Antonio, TX; SygnaMap, Inc., San Antonio, TX;
Systems & Technology Research LLC, Woburn, MA; Texas A&M University
System Health Science Center, Bryan, TX; The Children's Hospital of
Philadelphia, Philadelphia, PA; The Medical College of Wisconsin, Inc.,
Milwaukee, WI; The Medical University of South Carolina, Charleston,
SC; The Methodist Hospital Research Institute,
[[Page 52094]]
Houston, TX; The Regents of the University of California, San
Francisco, San Francisco, CA; The University of Kansas Medical Center
Research Institute, Inc., Kansas City, KS; The University of Texas at
Arlington, Arlington, TX; The University of Texas Health Science Center
at San Antonio, San Antonio, TX; Tonix Pharmaceuticals, Chatham, NJ;
TQIntelligence, Inc., Tucker, GA; Tremedics Medical Devices LLC, Fort
Worth, TX; Trustees of the University of Pennsylvania dba Clinical
Practices of the University of Pennsylvania, Philadelphia, PA; UC
Berkeley Haas Institute for Business Innovation, Berkeley, CA; UCSF:
Eureka Research Platform, San Francisco, CA; University of Alabama at
Birmingham, Birmingham, AL; University of Chicago, Chicago, IL;
University of Colorado Anschutz Medical Campus, Aurora, CO; University
of Iowa, Iowa City, IA; University of Massachusetts Medical School,
Worcester, MA; University of the Virgin Islands, St. Thomas, VI;
University of Utah, Salt Lake City, UT; Vanderbilt University Medical
Center, Nashville, TN; Women's Health Access Matters, Greenwich, CT;
Yunu, Inc., Cary, NC; and ZS Associates, Inc., Evanston, IL, have been
added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and the CX Hub intends to file
additional written notifications disclosing all changes in membership.
On January 11, 2024, the CX Hub filed its original notification
pursuant to section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to section 6(b) of
the Act on April 16, 2024 (89 FR 26929).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13623 Filed 6-20-24; 8:45 am]
BILLING CODE P
